Login / Signup

A Novel Anti-nucleocapsid Antibody Avidity Method for Identifying SARS-CoV-2 Reinfections.

Liam GoldingAllison W WattsJacob ShewMarina Viñeta ParamoLouise C MâsseDavid M GoldfarbBahaa Abu-RayaPascal M Lavoie
Published in: The Journal of infectious diseases (2024)
Detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections is challenging with current serology assays and is further complicated by the marked decrease in routine viral testing practices as viral transmission increased during Omicron. Here, we provide proof-of-principle that high-avidity anti-nucleocapsid (N) antibodies detects reinfections after a single infection with higher specificity (85%; 95% confidence interval [95% CI], 80%-90%) compared to anti-N antibody levels (72%; 95% CI, 66%-79%) in a vaccinated cohort. This method could be used to retroactively investigate the epidemiology and incremental long-term health consequences of SARS-CoV-2 reinfections.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • healthcare
  • public health
  • primary care
  • coronavirus disease
  • mental health
  • risk factors
  • high throughput
  • clinical practice
  • risk assessment
  • climate change